The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
暂无分享，去创建一个
[1] H. Ozen,et al. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? , 2006, The Journal of urology.
[2] M. Grimm,et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. , 2003, The Journal of urology.
[3] V. Reuter,et al. Impact of a second transurethral resection on the staging of T1 bladder cancer. , 2002, Urology.
[4] H. Habermann,et al. Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? , 2002, Urology.
[5] Gerhard Jakse,et al. Guidelines on bladder cancer. , 2002, European urology.
[6] H. Herr,et al. The value of a second transurethral resection in evaluating patients with bladder tumors. , 2000, The Journal of urology.
[7] H. Huland,et al. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. , 1991, The Journal of urology.
[8] A. Böhle,et al. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. , 2003, The Journal of urology.